EMBC
Embecta Corp.
$3.33
+$0.05(+1.52%)
41
Overall
80
Value
9
Tech
36
Quality
Market Cap
$196.97M
Volume
1.46M
52W Range
$2.77 - $15.55
Target Price
$4.00
Company Overview
| Mkt Cap | $196.97M | Price | $3.33 |
| Volume | 1.46M | Change | +1.52% |
| P/E Ratio | 2.1 | Open | $3.32 |
| Revenue | $1.1B | Prev Close | $3.28 |
| Net Income | $95.4M | 52W Range | $2.77 - $15.55 |
| Div Yield | 0.04% | Target | $4.00 |
| Overall | 41 | Value | 80 |
| Quality | 36 | Technical | 9 |
No chart data available
About Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Latest News
Embecta Completes Owen Mumford Acquisition to Expand Devices
TipRanks Auto-Generated Newsdesk•13 days ago
Embecta’s Earnings Call: Growth Bets Amid Sharp Setback
TipRanks Auto-Generated Newsdesk•23 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EMBC | $3.33 | +1.5% | 1.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |